Chiron Corporation (CHIR) Submits Written Testimony To Government Reform Committee Hearing On Influenza Vaccine Supply; CEO Howard Pien Pledges Company's Commitment To U.S. Influenza Vaccine Market
10/19/2005 5:11:47 PM
--Chiron Corporation (Nasdaq:CHIR) today announced that president and chief executive officer Howard Pien has submitted written testimony for today's Government Reform Committee Hearing on "The Nation's Flu Shot Shortage: How it Happened and Where We Go From Here."
comments powered by